COPD Home > Alupent Inhaler

People who are affected by bronchospasms might have been given the prescription drug Alupent® (metaproterenol sulfate). The inhaler form is no longer available in the United States. The manufacturer decided to stop making it in order to comply with regulations concerning chlorofluorocarbons (CFCs), chemicals that may deplete the ozone layer. Had Alupent been more popular, the manufacturer might have chosen to reformulate the drug without CFCs, instead of just discontinuing it.
(Click Alupent to learn more about this drug, which is also available in tablet, syrup, and nebulizer form. This article addresses possible side effects, dosing guidelines, generic availability, and more.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.